TransEnterix CEO steps down amid company’s financial struggles


The CEO of a Triangle bio-tech firm is stepping down as the company continues to look for ways to finance its operations beyond the first quarter of next year.

Research Triangle Park-based TransEnterix (NYSE: TRXC) has announced its longtime president and CEO – Todd Pope – is stepping down effective immediately.

But according to a company statement, Pope will remain on as a "senior advisor to the company."

Pope was named CEO in 2008. His base salary in 2018 was $480,800, according to the…

Previous Manufacturer of the Year 2019, Goodwell Co., Product of the Year
Next Second local life sciences IPO this week reels in $52 million